BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 3121822)

  • 1. Immunology of premalignant and malignant conditions of the oral cavity. II. Circulating immune complexes.
    Balaram P; Pillai MR; Abraham T
    J Oral Pathol; 1987 Sep; 16(8):389-91. PubMed ID: 3121822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating immune complexes as an immunological marker in premalignant and malignant lesions of the oral cavity.
    Remani P; Ankathil R; Vijayan KK; Haseena Beevi VM; Rajendran R; Vijayakumar T
    Cancer Lett; 1988 Jun; 40(2):185-91. PubMed ID: 3383176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Betel nut chewing, oral premalignant lesions, and the oral microbiome.
    Hernandez BY; Zhu X; Goodman MT; Gatewood R; Mendiola P; Quinata K; Paulino YC
    PLoS One; 2017; 12(2):e0172196. PubMed ID: 28225785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pilot survey of oral mucosa in areca (betel) nut chewers on Hainan Island of the People's Republic of China.
    Pindborg JJ; Zheng KH; Kong CR; Lin FX
    Community Dent Oral Epidemiol; 1984 Jun; 12(3):195-6. PubMed ID: 6589113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum circulating immune complexes as prognostic indicators in premalignant and malignant lesions of oral cavity during and following radiotherapy.
    Rai S; Mody RN
    J Cancer Res Ther; 2012 Jan; 8 Suppl 1():S116-22. PubMed ID: 22322729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral mucosal lesions associated with betel quid, areca nut and tobacco chewing habits: consensus from a workshop held in Kuala Lumpur, Malaysia, November 25-27, 1996.
    Zain RB; Ikeda N; Gupta PC; Warnakulasuriya S; van Wyk CW; Shrestha P; Axéll T
    J Oral Pathol Med; 1999 Jan; 28(1):1-4. PubMed ID: 9890449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Betel quid without tobacco as a risk factor for oral precancers.
    Jacob BJ; Straif K; Thomas G; Ramadas K; Mathew B; Zhang ZF; Sankaranarayanan R; Hashibe M
    Oral Oncol; 2004 Aug; 40(7):697-704. PubMed ID: 15172639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral precancerous disorders associated with areca quid chewing, smoking, and alcohol drinking in southern Taiwan.
    Chung CH; Yang YH; Wang TY; Shieh TY; Warnakulasuriya S
    J Oral Pathol Med; 2005 Sep; 34(8):460-6. PubMed ID: 16091112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell mediated and humoral immune responses in oral submucous fibrosis.
    Rajendran R; Sugathan CK; Remani P; Ankathil R; Vijayakumar T
    Cancer; 1986 Dec; 58(12):2628-31. PubMed ID: 3779612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of betel quid and cigarette on multistate progression of oral pre-malignancy.
    Yen AM; Chen SC; Chang SH; Chen TH
    J Oral Pathol Med; 2008 Aug; 37(7):417-22. PubMed ID: 18410311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The precancer risk of betel quid chewing, tobacco use and alcohol consumption in oral leukoplakia and oral submucous fibrosis in southern Taiwan.
    Lee CH; Ko YC; Huang HL; Chao YY; Tsai CC; Shieh TY; Lin LM
    Br J Cancer; 2003 Feb; 88(3):366-72. PubMed ID: 12569378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The oral health consequences of chewing areca nut.
    Trivedy CR; Craig G; Warnakulasuriya S
    Addict Biol; 2002 Jan; 7(1):115-25. PubMed ID: 11900631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiological survey of oral submucous fibrosis and leukoplakia in aborigines of Taiwan.
    Yang YH; Lee HY; Tung S; Shieh TY
    J Oral Pathol Med; 2001 Apr; 30(4):213-9. PubMed ID: 11302240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of CD44s, CD44v5, CD44v6 and CD44v7-8 in betel quid chewing-associated oral premalignant lesions and squamous cell carcinomas in Taiwan.
    Kuo MY; Cheng SJ; Chen HM; Kok SH; Hahn LJ; Chiang CP
    J Oral Pathol Med; 1998 Oct; 27(9):428-33. PubMed ID: 9790096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum copper and zinc levels in premalignant and malignant lesions of the oral cavity.
    Varghese I; Sugathan CK; Balasubramoniyan G; Vijayakumar T
    Oncology; 1987; 44(4):224-7. PubMed ID: 3614812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Total hemolytic complement (CH50) and its fractions (C3 and C4) in the sera of patients with premalignant and malignant lesions of the oral cavity.
    Rajendran R; Remani P; Vijayakumar T; Vasudevan DM
    Ann Dent; 1990; 49(1):36-8, 51. PubMed ID: 2346298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of p53 protein in betel- and tobacco-related human oral dysplasia and squamous-cell carcinoma in India.
    Kaur J; Srivastava A; Ralhan R
    Int J Cancer; 1994 Aug; 58(3):340-5. PubMed ID: 8050814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of arecoline on the release of cytokines using cultured peripheral blood mononuclear cells from patients with oral mucous diseases.
    Hsu HJ; Chang KL; Yang YH; Shieh TY
    Kaohsiung J Med Sci; 2001 Apr; 17(4):175-82. PubMed ID: 11482128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Salivary level of interleukin-8 in oral precancer and oral squamous cell carcinoma.
    Punyani SR; Sathawane RS
    Clin Oral Investig; 2013 Mar; 17(2):517-24. PubMed ID: 22526890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral lesions, genotoxicity and nitrosamines in betel quid chewers with no obvious increase in oral cancer risk.
    Stich HF; Rosin MP; Brunnemann KD
    Cancer Lett; 1986 Apr; 31(1):15-25. PubMed ID: 3697952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.